Beverly Hills Private Wealth, LLC

Position in GSK — GSK plc

CIK 1965710 BEVERLY HILLS, CA

Position in GSK

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$1,740,395

-$601,426 QoQ

Shares Held

33,201

-21.8% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.41%

of 13F equity value

Holder Rank

#282

of 1,032 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Beverly Hills Private Wealth, LLC holds $13,330,659 across 9 Drug Manufacturers - General names. GSK ranks #3 (13.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	14,225	$3,612,722
2	NVO	Novo Nordisk A S	63,562	$3,047,161
3	GSK	GSK plc This page	33,201	$1,740,395
4	ABBV	AbbVie Inc.	6,164	$1,551,108
5	LLY	ELI LILLY & Co	994	$1,192,233
6	AMGN	Amgen Inc	2,339	$846,998
7	MRK	Merck & Co., Inc.	5,600	$719,600
8	NVS	Novartis AG	2,596	$406,845

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,740,395	33,201	-21.8%	Shares	Sole	2026-08-07
2026-03-31	$2,341,821	42,432	+14.0%	Shares	Defined	2026-05-04
2025-12-31	$1,825,415	37,223	-4.6%	Shares	Sole	2026-02-17
2025-09-30	$1,684,143	39,021	+3.9%	Shares	Sole	2025-11-10
2025-06-30	$1,442,378	37,562	+13.5%	Shares	Sole	2025-07-29
2025-03-31	$1,282,215	33,098	+12.6%	Shares	Defined	2025-04-30
2024-12-31	$994,204	29,397	+94.6%	Shares	Sole	2025-02-14
2024-09-30	$617,653	15,109	+16.7%	Shares	Sole	2024-11-12
2024-06-30	$498,420	12,946	-47.2%	Shares	Sole	2024-08-08
2024-03-31	$1,050,357	24,501	+26.9%	Shares	Sole	2024-05-09
2023-12-31	$715,664	19,311	+11.6%	Shares	Sole	2024-01-30
2023-09-30	$627,196	17,302	-27.9%	Shares	Sole	2023-11-08
2023-06-30	$854,754	23,983	+310.0%	Shares	Sole	2023-08-10
2023-03-31	$208,143	5,850	—	Shares	Sole	2023-05-04
No filing history on record for this holder in this stock.